About Careers MedBlog Contact us

Chinese Herbal Weight Loss Supplement Contains Banned Drugs, FDA Warns

by VR Sreeraman on July 9, 2010 at 3:30 PM
Font : A-A+

 Chinese Herbal Weight Loss Supplement Contains Banned Drugs, FDA Warns

The US drug safety watchdog on Thursday warned that a Chinese herbal slimming supplement sold in shops and online contains active drugs not listed on its label, including a stimulant known to cause heart damage.

The weight loss supplement sold under the name Que She and marketed as "an all-natural blend of Chinese herbs" contains not only fenfluramine, a stimulant withdrawn from the US market in 1997 after studies showed it caused serious heart valve damage, but also three other potentially harmful drugs.


The other drugs found in Que She were the beta-blocker propranolol, which can harm people with asthma and certain heart conditions; prescription weight loss drug sibutramine, which has been linked with increased risk of heart attack and stroke in patients with a history of heart disease; and the stimulant ephedrine.

The drugs in Que She could be dangerous on their own in certain groups of patients, and could "interact with other medications and result in a serious adverse event," the FDA warned, urging anyone who has taken the weight loss supplement to consult a health care professional.

The Diet Spotlight website described Que She as a compound of 11 Chinese herbs that "purportedly helps a person lose weight by suppressing appetite and increasing metabolism."

Several websites that sold the slimming aid had removed Que She from the list of products they sell shortly after the FDA issued its warning on Thursday.

Source: AFP


Recommended Reading

Latest Drug News

 India's First Urinary Incontinence Drug Launched
India's First Urinary Incontinence Drug Fesobig may offer Affordable treatment for Overactive Bladder (OAB), a widely prevalent problem among Indian men and women.
 New Ray of Hope for Atrial Fibrillation Patients With Kidney Disease
Oral anticoagulant drugs, particularly Rivaroxaban presented superior efficacy and safety than warfarin in atrial fibrillation patients with chronic kidney disease.
Anti-viral Drug Bulevirtide Helps Treat Chronic Hepatitis D
Patients with hepatitis D virus-related chronic advanced liver disease are treated with an antiviral therapy.
Antiviral Drug Paxlovid Linked to Lower Risk of Hospital Admission
Among people with COVID-19, Paxlovid drug was found to reduce hospitalization and death risk by 90%, revealed study.
Price Cap Move Will Place Eli Lilly Strongly in Insulin Market
Lilly will likely maintain or increase its market share in the insulin space as the average out-of-pocket cost for its insulin products is already below the $35 price cap.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Chinese Herbal Weight Loss Supplement Contains Banned Drugs, FDA Warns Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests